Privia Health Group, Inc.

PRVA

Privia Health Group, Inc.

PRVA

Insider Sentiment (TTM):

Last Purchase:2024-06-11Last Sale:2026-06-29Shares Purchased (TTM):0Shares Sold (TTM):309,578

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:115,316,945Shares Outstanding:124,152,526Institutional Ownership Pct.:92.88%

Earnings Market Reaction:

Filing Date:2026-05-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Health Services

LFST WGS USPH INNV PNTG TALK

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	420	480	441	390	469	491	422	387	351	390	330	318
Accounts Receivable Net Current	514	401	499	444	389	316	409	370	346	291	350	320
Prepaid Expense And Other Assets Current	33	30	31	49	28	27	23	22	31	21	17	16
Assets Current	966	911	971	883	886	835	854	780	728	701	698	654
Assets Noncurrent
Property Plant And Equipment Net	0	1	1	1	1	1	1	2	2	2	3	3
Operating Lease Right Of Use Asset	8	9	6	6	5	5	5	6	6	7	7	8
Finite Lived Intangible Assets Net	213	216	168	170	108	110	103	105	106	108	107	96
Goodwill	210	210	172	172	142	142	139	139	139	139	136	135
Deferred Income Tax Assets Net	0	2	17	24	25	26	28	31	34	35	35	37
Other Assets Noncurrent	21	21	17	17	17	17	15	15	15	9	7	5
Assets Noncurrent	452	458	380	390	297	301	292	298	303	299	295	284
Assets	1,418	1,369	1,351	1,273	1,184	1,136	1,146	1,078	1,032	1,000	992	938
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	81	97	85	74	68	82	66	61	51	58	54	49
Liability For Unpaid Claims And Claims Adjustment …	519	470	496	458	400	365	411	366	350	326	337	306
Operating Lease Liability Current	2	2	3	3	2	3	3	3	3	3	3	3
Liabilities Current	601	569	583	535	471	449	479	430	404	387	394	358
Liabilities Noncurrent
Operating Lease Liability Noncurrent	7	7	4	4	3	3	4	4	5	5	6	7
Deferred Income Tax Liabilities Net	0	-	-	-	-	-	-	-	-	-	-	-
Other Liabilities Noncurrent	4	3	2	0	0	0	0	0	0	0	1	1
Liabilities Noncurrent	11	10	5	4	3	3	4	4	5	6	7	8
Liabilities	612	578	588	539	474	452	483	434	409	393	401	366
Equity
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	1
Additional Paid In Capital	905	892	873	854	833	813	797	781	766	754	740	726
Retained Earnings Accumulated Deficit	-153	-156	-165	-172	-175	-179	-184	-187	-191	-194	-196	-202
Stockholders Equity	806	791	763	734	710	635	615	595	577	607	545	571
Minority Interest	53	54	54	51	50	48	47	48	46	46	46	46
Liabilities And Stockholders Equity	1,418	1,369	1,351	1,273	1,184	1,136	1,146	1,078	1,032	1,000	992	938
Allowance For Doubtful Accounts Receivable Current	-	15	-	-	-	9	-	-	-	-	-	-
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000
Common Stock Shares Issued	126	124	123	123	121	120	120	119	119	118	118	117
Shares Outstanding	126	124	123	123	121	120	120	119	119	118	118	117

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-10.34%	6.59%	-	-	-	-	-	-	-	-	-	-
2025	-9.21%	-12.25%	-21.40%	18.09%	22.81%	33.21%	1.63%	0.63%	-0.17%	-10.57%	1.14%	-3.37%
2024	-3.66%	-3.61%	13.48%	4.08%	-6.56%	-8.79%	-4.66%	-11.90%	0.22%	-8.33%	-6.99%	-1.73%
2023	-	-	-	-4.16%	-18.25%	-13.61%	-4.34%	0.85%	-11.44%	-10.66%	-17.63%	-23.01%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.61	1.60	1.67	1.65	1.88	1.86	1.78	1.81	1.80	1.81	1.77	1.82
Quick Ratio	1.55	1.55	1.61	1.56	1.82	1.80	1.73	1.76	1.73	1.76	1.73	1.78
Working Capital	364.72M	342.48M	388.01M	348.11M	415.66M	385.68M	374.28M	350.08M	324.34M	313.85M	303.48M	295.56M
Leverage & Debt
Debt to Equity	0.76	0.73	0.77	0.73	0.67	0.66	0.79	0.73	0.71	0.65	0.74	0.64
Interest Coverage TTM	-	-	-	-	-	5.69	2.26	1.48	1.55	2.47	3.22	2.80
Debt Ratio	0.43	0.42	0.44	0.42	0.40	0.40	0.42	0.40	0.40	0.39	0.40	0.39
Efficiency & Turnover
Asset Turnover TTM	1.73	1.69	1.64	1.62	1.63	1.63	1.61	1.68	1.77	1.85	1.76	1.79
Days Sales Outstanding TTM	73.31	61.65	81.13	78.19	74.45	63.79	80.71	74.25	65.67	52.88	68.84	64.64
Receivables Turnover TTM	4.98	5.92	4.50	4.67	4.90	5.72	4.52	4.92	5.56	6.90	5.30	5.65
Per Share Metrics
Diluted EPS TTM	0.17	0.18	0.13	0.11	0.12	0.11	0.13	0.14	0.16	0.19	0.29	0.26
Free Cash Flow Per Share TTM	-0.34	-0.14	0.13	-0.03	0.93	0.86	0.82	0.73	0.51	0.48	0.18	0.13
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	1.62%	1.61%	1.38%	1.03%	1.19%	0.98%	0.77%	0.76%	0.87%	1.25%	1.36%	0.75%
Net Profit Margin TTM	0.97%	1.08%	0.83%	0.72%	0.87%	0.83%	0.92%	1.06%	1.17%	1.39%	2.29%	2.13%
Growth Metrics
Net Revenue Growth (1Y)	24.72%	22.26%	19.01%	12.05%	6.79%	4.74%	8.54%	12.52%	18.02%	22.19%	24.75%	28.12%
Net Income Growth (1Y)	39.32%	59.33%	7.29%	-23.85%	-20.55%	-37.67%	-56.23%	-44.21%	28.28%	-368.83%	-196.21%	-166.52%
EPS Growth (1Y)	35.36%	55.71%	4.58%	-25.61%	-21.94%	-39.07%	-56.98%	-45.68%	24.49%	-354.93%	-191.29%	-162.24%
Valuation Metrics
P/E TTM	117.35	126.39	179.92	205.56	173.36	162.27	137.60	115.55	118.08	116.48	74.76	94.30
P/B TTM	3.17	3.66	4.01	3.83	3.82	3.42	3.54	3.48	4.02	4.43	4.97	5.31
P/S TTM	1.14	1.36	1.50	1.48	1.50	1.34	1.27	1.22	1.38	1.62	1.71	2.01
Market Cap	2.55B	2.90B	3.06B	2.81B	2.71B	2.33B	2.18B	2.07B	2.32B	2.69B	2.70B	3.03B
Enterprise Value	2.13B	2.42B	2.62B	2.42B	2.24B	1.84B	1.76B	1.69B	1.97B	2.30B	2.37B	2.72B
Calculated Values
Free Cash Flow TTM	-42.37M	-16.97M	15.39M	-3.45M	112.11M	102.33M	97.86M	87.14M	60.21M	55.82M	20.88M	14.56M
Net Debt	-419.52M	-479.69M	-441.35M	-390.13M	-469.33M	-491.15M	-422.00M	-387.35M	-351.14M	-389.51M	-330.39M	-317.95M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-29Sale

Owner: Morris, Matthew Shawn

Title: -

Shares: 63,212

Price/Share: $25.33

Value: $1,601,159.96

Shares Owned: 76,651

Relationship: Director

Ownership: Direct

2026-06-26Sale

Owner: Mountcastle, David

Title: EVP & Chief Financial Officer

Shares: 17,196

Price/Share: $25.18

Value: $432,995.28

Shares Owned: 211,462

Relationship: Officer

Ownership: Direct

2026-05-12Sale

Owner: Mehrotra, Parth

Title: Chief Executive Officer

Shares: 15,647

Price/Share: $22.64

Value: $354,248.08

Shares Owned: 434,357

Relationship: Director,Officer

Ownership: Direct

2026-05-11Sale

Owner: Mountcastle, David

Title: EVP & Chief Financial Officer

Shares: 3,385

Price/Share: $22.60

Value: $76,501.00

Shares Owned: 211,462

Relationship: Officer

Ownership: Direct

2026-05-04Sale

Owner: Morris, Matthew Shawn

Title: -

Shares: 1,017

Price/Share: $24.96

Value: $25,384.32

Shares Owned: 68,188

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-29	Morris, Matthew Shawn	Director	-	Direct	Sale	63,212	25.33	$1,601,159.96	76,651	4
2026-06-26	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	17,196	25.18	$432,995.28	211,462	4
2026-05-12	Mehrotra, Parth	Director,Officer	Chief Executive Officer	Direct	Sale	15,647	22.64	$354,248.08	434,357	4
2026-05-11	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	3,385	22.60	$76,501.00	211,462	4
2026-05-04	Morris, Matthew Shawn	Director	-	Direct	Sale	1,017	24.96	$25,384.32	68,188	4
2026-05-04	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	1,206	25.00	$30,150.00	214,847	4
2026-04-02	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	5,566	20.85	$116,051.10	214,847	4
2026-03-16	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	6,391	22.11	$141,305.01	220,413	4
2026-03-16	Mehrotra, Parth	Director,Officer	Chief Executive Officer	Direct	Sale	26,509	22.11	$586,113.99	555,443	4
2026-03-13	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	6,565	21.52	$141,278.80	226,804	4
2026-03-13	Mehrotra, Parth	Director,Officer	Chief Executive Officer	Direct	Sale	27,229	21.52	$585,968.08	581,952	4
2026-03-10	Mehrotra, Parth	Director,Officer	Chief Executive Officer	Direct	Sale	21,097	22.71	$479,112.87	322,698	4
2026-03-09	Fargis, Edward C	Officer	EVP & General Counsel	Direct	Sale	4,949	22.84	$113,035.16	83,711	4
2026-03-09	Mehrotra, Parth	Director,Officer	Chief Executive Officer	Direct	Sale	41,999	23.02	$966,816.98	343,795	4
2026-03-09	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	5,829	22.84	$133,134.36	161,903	4
2026-02-27	Morris, Matthew Shawn	Director	-	Direct	Sale	16,550	25.00	$413,750.00	68,188	4
2026-02-27	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	7,697	25.05	$192,809.85	172,909	4
2025-12-12	Morris, Matthew Shawn	Director	-	Direct	Sale	13,647	25.01	$341,311.47	68,188	4
2025-12-12	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	23,887	25.03	$597,891.61	172,909	4
2025-05-13	Mehrotra, Parth	Director,Officer	Chief Executive Officer	Direct	Sale	15,909	24.52	$390,088.68	407,234	4
2025-05-12	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	3,322	24.99	$83,016.78	172,909	4
2025-05-01	Mehrotra, Parth	Director,Officer	Chief Executive Officer	Direct	Sale	17,365	23.08	$400,784.20	436,916	4
2025-04-30	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	3,445	23.33	$80,371.85	176,231	4
2025-04-30	Morris, Matthew Shawn	Director	-	Direct	Sale	10,309	23.33	$240,508.97	59,792	4
2025-04-02	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	5,630	22.38	$125,999.40	179,676	4
2025-03-12	Mehrotra, Parth	Director,Officer	Chief Executive Officer	Direct	Sale	10,514	24.03	$252,651.42	469,381	4
2025-03-11	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	2,872	23.88	$68,583.36	185,306	4
2025-03-11	Fargis, Edward C	Officer	EVP & General Counsel	Direct	Sale	2,438	23.88	$58,219.44	93,054	4
2025-03-11	Mehrotra, Parth	Director,Officer	Chief Executive Officer	Direct	Sale	9,294	23.88	$221,940.72	479,895	4
2025-02-14	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	100,000	25.15	$2,515,000.00	157,727	4
2024-09-10	Mehrotra, Parth	Director,Officer	Chief Executive Officer	Direct	Sale	135,142	18.50	$2,500,127.00	247,771	4
2024-06-11	Boehler, Adam	Director	-	Indirect	Purchase	364	16.50	$6,006.00	5,773,522	4
2024-05-29	Boehler, Adam	Director	-	Indirect	Purchase	5,306	16.50	$87,549.00	5,773,158	4
2024-05-24	Boehler, Adam	Director	-	Indirect	Purchase	4,280	16.49	$70,577.20	5,767,852	4
2024-05-23	Boehler, Adam	Director	-	Indirect	Purchase	172,642	16.28	$2,810,611.76	5,763,572	4
2024-05-23	Mccarthy, Thomas A	Director	-	Direct	Purchase	10,000	16.37	$163,700.00	52,611	4
2024-05-10	Bartrum, Thomas	Other	-	Direct	Sale	1,506	17.88	$26,927.28	102,356	4
2024-05-10	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	2,232	17.88	$39,908.16	257,727	4
2024-05-10	Mehrotra, Parth	Director,Officer	Chief Executive Officer	Direct	Sale	13,869	17.88	$247,977.72	247,771	4
2024-04-30	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	2,320	18.42	$42,734.40	259,959	4
2024-04-30	Morris, Matthew Shawn	Director	-	Direct	Sale	11,059	18.42	$203,706.78	70,101	4
2024-04-30	Bartrum, Thomas	Other	-	Direct	Sale	2,252	18.42	$41,481.84	103,862	4
2024-04-30	Mehrotra, Parth	Director,Officer	Chief Executive Officer	Direct	Sale	12,219	18.42	$225,073.98	261,640	4
2024-04-02	Mountcastle, David	Officer	EVP & Chief Financial Officer	Direct	Sale	3,933	17.77	$69,889.41	262,279	4
2024-03-11	Sullivan, William M	Director	-	Indirect	Sale	400	23.02	$9,208.00	5,445,018	4
2024-01-25	Sullivan, William M	Director	-	Indirect	Sale	12,000	23.13	$277,560.00	5,452,533	4
2023-12-28	Sullivan, William M	Director	-	Indirect	Sale	12,000	23.97	$287,640.00	5,474,484	4
2023-12-14	Sullivan, William M	Director	-	Indirect	Sale	12,000	24.00	$288,000.00	5,486,484	4
2023-09-15	Sullivan, William M	Director	-	Indirect	Sale	18,153	24.84	$450,920.52	5,510,484	4
2023-09-05	Bartrum, Thomas	Officer	EVP, General Counsel	Direct	Sale	15,000	25.77	$386,550.00	106,114	4
2023-09-01	Sullivan, William M	Director	-	Indirect	Sale	18,153	26.46	$480,328.38	5,528,637	4
2023-08-18	Sullivan, William M	Director	-	Indirect	Sale	18,153	25.06	$454,914.18	5,546,790	4
2023-08-04	Sullivan, William M	Director	-	Indirect	Sale	18,153	26.88	$487,952.64	5,564,943	4
2023-08-03	Bartrum, Thomas	Officer	EVP, General Counsel	Direct	Sale	15,000	27.01	$405,150.00	106,114	4
2023-07-31	Mehrotra, Parth	Director,Officer	Chief Executive Officer	Direct	Sale	31,744	28.03	$889,784.32	153,974	4
2023-07-21	Sullivan, William M	Director	-	Indirect	Sale	18,153	26.82	$486,863.46	5,583,096	4
2023-07-19	Mehrotra, Parth	Director,Officer	Chief Executive Officer	Direct	Sale	12,414	28.06	$348,336.84	153,974	4
2023-07-07	Sullivan, William M	Director	-	Indirect	Sale	18,153	25.34	$459,997.02	5,601,249	4
2023-07-03	Bartrum, Thomas	Officer	EVP, General Counsel	Direct	Sale	15,000	25.68	$385,200.00	106,114	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

92.88%

Inst. Shares: 115,316,945

Shares Outstanding: 124,152,526

2025-12-31

94.35%

Inst. Shares: 115,273,255

Shares Outstanding: 122,176,587

2025-09-30

93.03%

Inst. Shares: 114,210,087

Shares Outstanding: 122,768,890

2025-06-30

92.20%

Inst. Shares: 112,607,987

Shares Outstanding: 122,132,245

2025-03-31

95.62%

Inst. Shares: 115,336,728

Shares Outstanding: 120,623,670

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	115,316,945	124,152,526	92.88%
2025-12-31	115,273,255	122,176,587	94.35%
2025-09-30	114,210,087	122,768,890	93.03%
2025-06-30	112,607,987	122,132,245	92.20%
2025-03-31	115,336,728	120,623,670	95.62%
2024-12-31	112,921,792	119,402,749	94.57%
2024-09-30	111,648,541	119,658,574	93.31%
2024-06-30	104,568,939	119,301,350	87.65%
2024-03-31	104,156,774	118,505,320	87.89%
2023-12-31	103,853,424	116,731,406	88.97%
2023-09-30	101,969,459	117,602,059	86.71%
2023-06-30	95,671,294	116,161,251	82.36%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Privia Health Group, Inc. (PRVA) — SEC Financial Statements & Analysis

Privia Health Group, Inc. (PRVA) is a services-health services company, incorporated in DE. Privia Health Group, Inc. trades on Nasdaq as: PRVA. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Privia Health Group, Inc. reported a 24.72% year-over-year revenue growth, a Debt-to-Equity ratio of 0.76x, a Price-to-Sales (P/S) ratio of 1.14x (TTM), a Price-to-Book (P/B) ratio of 3.17 (TTM), at a market cap of $2.55B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 24.72%
Debt To Equity: 0.76x
P/S TTM: 1.14x
P/B TTM: 3.17
Market Cap: $2.55B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Privia Health Group, Inc. in?

Privia Health Group, Inc. (PRVA) operates in the Services-Health Services industry.

What is PRVA's market cap?

Privia Health Group, Inc. (PRVA) has a market capitalization of $2.55B as of 2026-03-31.

What is PRVA's P/E ratio?

Privia Health Group, Inc. (PRVA)'s trailing twelve month P/E ratio is 117.35x as of 2026-03-31.

What exchange does PRVA trade on?

Privia Health Group, Inc. (PRVA) trades on the Nasdaq.

Where is Privia Health Group, Inc. incorporated?

Privia Health Group, Inc. is incorporated in DE.

Privia Health Group, Inc. (PRVA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.